Cite
APA Citation
Banna, G., Signorelli, D., Metro, G., Galetta, D., De Toma, A., Cantale, O., Banini, M., Friedlaender, A., Pizzutillo, P., Garassino, M., & Addeo, A. (n.d.). baseline neutrophil-to-lymphocyte ratio and PD-L1 expression level or LDH value may predict outcome of patients with high PD-L1 advanced non-small cell lung cancer treated with first-line pembrolizumab. Lung cancer, 139, S58–S59. http://access.bl.uk/ark:/81055/vdc_100099354099.0x000042